Grail (GRAL) Cash & Current Investments (2023 - 2026)
Grail's (GRAL) quarterly Cash & Current Investments came in at $823.1 million in Q1 2026, up 22.02% YoY from $674.6 million in Q1 2025, and down 8.99% on a QoQ basis from $904.4 million in Q4 2025.
Grail (GRAL) Cash & Current Investments (2023 - 2026) Analysis & Trends
Grail (GRAL) has 4 years of Cash & Current Investments data on file, last reported at $823.1 million in Q1 2026.
- Quarterly Cash & Current Investments rose 22.02% year-over-year to $823.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $823.1 million (up 22.02% YoY) and the FY2025 annual result came in at $904.4 million, up 18.46% from the prior year.
- Cash & Current Investments slipped to $823.1 million in Q1 2026, from $904.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $958.8 million in Q2 2024 to a low of $97.3 million in Q4 2023.
- A 4-year average of $566.0 million and a median of $638.7 million in 2025 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2024 — Cash & Current Investments jumped 684.76% — and 2025, when it tumbled 37.14%.
- Tracing GRAL's Cash & Current Investments over 4 years: stood at $97.3 million in 2023, then jumped by 684.76% to $763.5 million in 2024, then increased by 18.46% to $904.4 million in 2025, then decreased by 8.99% to $823.1 million in 2026.
- The last three Cash & Current Investments figures came in at $823.1 million (Q1 2026), $904.4 million (Q4 2025), and $540.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 4.06 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 4.35 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 1.10 Bn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 1.81 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.08 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 196.93 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 1.17 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 51.40 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 141.80 Mn |
| 10 | Grail | 3.56 Bn | 2.70 Bn | 21.34 Mn | 861.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 861.65 Mn |
| Mar 31, 2026 | 823.14 Mn |
| Dec 31, 2025 | 904.43 Mn |
| Sep 30, 2025 | 540.14 Mn |
| Jun 30, 2025 | 602.75 Mn |
| Mar 31, 2025 | 674.60 Mn |
| Dec 31, 2024 | 763.47 Mn |
| Sep 30, 2024 | 853.55 Mn |
| Jun 30, 2024 | 958.85 Mn |
| Mar 31, 2024 | 199.72 Mn |
| Dec 31, 2023 | 97.29 Mn |
| Oct 1, 2023 | 143.84 Mn |
| Jun 30, 2023 | 230.62 Mn |